Mouse monoclonal antibodies with varying specificities against the Gag capsid of simian and human immunodeficiency virus (SIV/HIV) were generated by immunizing mice with whole inactivated SIVagmTYO-1. Monoclonal antibody AG3.0 showed the broadest reactivity recognizing the Gag capsid protein (p24-27) and Gag precursors p38, p55, and p150 of HIV-1, HIV-2, SIVmac, and SIVagm. Using overlapping peptides, the AG3.0 epitope was mapped in capsid to a sequence (SPRTLNA) conserved among HIV-1, HIV-2, SIVrcm, SIVsm/mac, and SIVagm related viruses. Because of its broad cross-reactivity, AG3.0 was used to develop an antigen capture assay with a lower detection limit of 100 pg/ml HIV-1 Gag p24. Interestingly, AG3.0 was found to have a faster binding on...
Monoclonal antibodies (MAbs) were raised against gag proteins of human immunodeficiency virus type I...
Neutralizing antibodies (NAb) able to react to heterologous viruses are generated during natural HIV...
Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, genetic...
AbstractAchieving humoral immunity against human immunodeficiency virus (HIV) is a major obstacle in...
AbstractA major limitation in the simian immunodeficiency virus (SIV) system has been the lack of re...
In an attempt to generate broadly cross-reactive, neutralizing monoclonal antibodies (MAbs) to simia...
Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, geneti...
The development of an effective HIV-1 vaccine remains a scientific and global health priority despit...
The development of an effective HIV-1 vaccine remains a scientific and global health priority despit...
Cynomolgus macaques are an increasingly important nonhuman primate model for HIV vaccine research. S...
The simian immunodeficiency virus (SIV) challenge model of lentiviral infection is often used as a m...
AbstractAntisera to 21 synthetic peptides containing hydrophilic sequences of simian immunodeficienc...
HIV-1 mucosal transmission begins with virus or virus-infected cells moving through mucus across muc...
A small fraction of HIV-1- infected humans develop broadly neutralizing antibodies (bNAbs) against H...
Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, genetic...
Monoclonal antibodies (MAbs) were raised against gag proteins of human immunodeficiency virus type I...
Neutralizing antibodies (NAb) able to react to heterologous viruses are generated during natural HIV...
Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, genetic...
AbstractAchieving humoral immunity against human immunodeficiency virus (HIV) is a major obstacle in...
AbstractA major limitation in the simian immunodeficiency virus (SIV) system has been the lack of re...
In an attempt to generate broadly cross-reactive, neutralizing monoclonal antibodies (MAbs) to simia...
Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, geneti...
The development of an effective HIV-1 vaccine remains a scientific and global health priority despit...
The development of an effective HIV-1 vaccine remains a scientific and global health priority despit...
Cynomolgus macaques are an increasingly important nonhuman primate model for HIV vaccine research. S...
The simian immunodeficiency virus (SIV) challenge model of lentiviral infection is often used as a m...
AbstractAntisera to 21 synthetic peptides containing hydrophilic sequences of simian immunodeficienc...
HIV-1 mucosal transmission begins with virus or virus-infected cells moving through mucus across muc...
A small fraction of HIV-1- infected humans develop broadly neutralizing antibodies (bNAbs) against H...
Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, genetic...
Monoclonal antibodies (MAbs) were raised against gag proteins of human immunodeficiency virus type I...
Neutralizing antibodies (NAb) able to react to heterologous viruses are generated during natural HIV...
Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, genetic...